heartbeat medical

heartbeat-med.com →

+33%

est. 2Y upside i

HealthcareSeries A

Stage: early. Country: Germany

Rank

#1829

Sector

Digital Health

Est. Liquidity

~3Y

Data Quality

Data: Low

Heartbeat Medical is a promising but early-stage digital health company with significant uncertainty due to stale financial data.

Last updated: July 3, 2026

Bull (10%)+166%

Revenue reaches ~$24.6M, exit multiple expands to 5x due to IPO window and category leadership from Helios partnership. Enterprise value $123M, but after 20% dilution, net upside ~166%.

Base (55%)+62%

Revenue ~$24.6M, exit multiple converges to 3.3x (average comp). Enterprise value $81.2M, net of 20% dilution yields ~62% upside.

Bear (35%)-28%

Revenue stalls or declines, exit multiple compresses to 1.5x. Enterprise value $36.9M, above preference, but after 20% dilution common return is -27.8%.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

52%

Total funding of $20.9M represents ~52% of the estimated $40M entry valuation, meaning preferred shareholders have a large claim ahead of common.

Dilution Risk

high

With no new round in 4+ years and likely need for capital, expect 15-25% dilution from a Series B within 2 years.

Secondary Liquidity

none

No secondary market activity detected; liquidity for shares is unavailable until an exit event.

Questions to Ask at the Interview

Strategic questions based on heartbeat medical's data — designed to show you've done your homework.

  • 1

    “How does Heartbeat Medical plan to expand beyond Germany and into other EU markets, given regulatory differences?”

  • 2

    “What is the current cash runway and what is the plan for the next funding round?”

  • 3

    “How does the company differentiate its platform from built-in PROMs features in major EHR systems?”

Community

Valuation Sentiment

Our model estimates +33% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.